Cargando…
Primary central nervous system vasculitis and headache: Ten themes
PURPOSE OF REVIEW: The primary central nervous system (CNS) vasculitides refers to clinicopathologic disorders that share the histopathology of inflammation of cerebral or spinal blood vessels. Unrecognized and therefore untreated, vasculitis of the CNS results in irreversible injury and disability...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624409/ https://www.ncbi.nlm.nih.gov/pubmed/37865827 http://dx.doi.org/10.1097/WCO.0000000000001225 |
_version_ | 1785130918298517504 |
---|---|
author | Younger, David S. |
author_facet | Younger, David S. |
author_sort | Younger, David S. |
collection | PubMed |
description | PURPOSE OF REVIEW: The primary central nervous system (CNS) vasculitides refers to clinicopathologic disorders that share the histopathology of inflammation of cerebral or spinal blood vessels. Unrecognized and therefore untreated, vasculitis of the CNS results in irreversible injury and disability making these disorders of paramount importance to clinicians. RECENT FINDINGS: Headache is an important clue to vasculitic involvement of CNS vessels. CNS vasculitis can be primary, in which only intracranial or spinal vessels are involved in the inflammatory process, or secondary to another known disorder with overlapping systemic involvement. The suspicion of vasculitis based on the history, clinical examination, and laboratory studies warrants prompt evaluation and treatment to prevent cerebral ischemia or infarction. SUMMARY: Primary CNS vasculitides can be diagnosed with certainty after intensive evaluation that includes tissue confirmation whenever possible. As in its systemic counterparts, clinicians must choose from among the available immune modulating, suppressive, and targeted immunotherapies to induce and maintain remission status and prevent relapse, tempered by anticipated medication adverse effects. |
format | Online Article Text |
id | pubmed-10624409 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-106244092023-11-04 Primary central nervous system vasculitis and headache: Ten themes Younger, David S. Curr Opin Neurol HEADACHE: Edited by Mark W. Green PURPOSE OF REVIEW: The primary central nervous system (CNS) vasculitides refers to clinicopathologic disorders that share the histopathology of inflammation of cerebral or spinal blood vessels. Unrecognized and therefore untreated, vasculitis of the CNS results in irreversible injury and disability making these disorders of paramount importance to clinicians. RECENT FINDINGS: Headache is an important clue to vasculitic involvement of CNS vessels. CNS vasculitis can be primary, in which only intracranial or spinal vessels are involved in the inflammatory process, or secondary to another known disorder with overlapping systemic involvement. The suspicion of vasculitis based on the history, clinical examination, and laboratory studies warrants prompt evaluation and treatment to prevent cerebral ischemia or infarction. SUMMARY: Primary CNS vasculitides can be diagnosed with certainty after intensive evaluation that includes tissue confirmation whenever possible. As in its systemic counterparts, clinicians must choose from among the available immune modulating, suppressive, and targeted immunotherapies to induce and maintain remission status and prevent relapse, tempered by anticipated medication adverse effects. Lippincott Williams & Wilkins 2023-12 2023-10-16 /pmc/articles/PMC10624409/ /pubmed/37865827 http://dx.doi.org/10.1097/WCO.0000000000001225 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
spellingShingle | HEADACHE: Edited by Mark W. Green Younger, David S. Primary central nervous system vasculitis and headache: Ten themes |
title | Primary central nervous system vasculitis and headache: Ten themes |
title_full | Primary central nervous system vasculitis and headache: Ten themes |
title_fullStr | Primary central nervous system vasculitis and headache: Ten themes |
title_full_unstemmed | Primary central nervous system vasculitis and headache: Ten themes |
title_short | Primary central nervous system vasculitis and headache: Ten themes |
title_sort | primary central nervous system vasculitis and headache: ten themes |
topic | HEADACHE: Edited by Mark W. Green |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624409/ https://www.ncbi.nlm.nih.gov/pubmed/37865827 http://dx.doi.org/10.1097/WCO.0000000000001225 |
work_keys_str_mv | AT youngerdavids primarycentralnervoussystemvasculitisandheadachetenthemes |